H.R. 2391: Medicaid Generic Drug Price Fairness Act of 2015

To amend title XIX of the Social Security Act to require the payment of an additional rebate to the State Medicaid plan in the case of increase in the price of a generic drug at a rate that is greater than the rate of inflation.

The bill’s titles are written by its sponsor.

What you can do



May 18, 2015


Referred to Committee on May 18, 2015

This bill was assigned to a congressional committee on May 18, 2015, which will consider it before possibly sending it on to the House or Senate as a whole.


Elijah Cummings

Representative for Maryland's 7th congressional district



Read Text »
Last Updated: May 18, 2015
Length: 5 pages


1% chance of being enacted according to PredictGov (details)


May 18, 2015

This is the first step in the legislative process.

Reported by Committee

Passed House

Passed Senate

Signed by the President

H.R. 2391 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 2391 — 114th Congress: Medicaid Generic Drug Price Fairness Act of 2015.” www.GovTrack.us. 2015. October 26, 2016 <https://www.govtrack.us/congress/bills/114/hr2391>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.